LWI
VRX

Long Wharf Investors’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Long Wharf Investors’s Portfolio VRX Stock Details VRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$657K Buy
5,211
+135
+3% +$17K 0.52% 55
2014
Q1 		$669K Sell
5,076
-1,412
-22% -$186K 0.57% 47
2013
Q4 		$762K Sell
6,488
-1,460
-18% -$171K 0.69% 34
2013
Q3 		$829K Sell
7,948
-1,847
-19% -$193K 0.79% 35
2013
Q2 		$843K Buy
+9,795
New +$843K 0.83% 35

Long Wharf Investors's VRX Position: Q2 2014 in Review

Long Wharf Investors increased its VALEANT PHARMACEUTICALS INTL (VRX) stake by 2.7% in Q2 2014, buying an estimated $17K and bringing the position to 5,211 shares worth $657K. The position accounts for 0.52% of the portfolio, ranked #55.

Long Wharf Investors first reported a position in VRX in Q2 2013 and has held it in 5 quarters since. The position peaked at $843K in Q2 2013. 1 fund tracked by Wall St. Rank holds VRX as of Q2 2014.

  • Long Wharf Investors held 5,211 shares of VALEANT PHARMACEUTICALS INTL worth $657K as of Q2 2014.
  • Long Wharf Investors bought 135 VALEANT PHARMACEUTICALS INTL shares in Q2 2014, an estimated $17K.
  • VALEANT PHARMACEUTICALS INTL made up 0.52% of Long Wharf Investors's portfolio in Q2 2014, its #55 holding.
  • Long Wharf Investors first reported a position in VALEANT PHARMACEUTICALS INTL in Q2 2013 and has held it in 5 quarters since.
  • Long Wharf Investors's VALEANT PHARMACEUTICALS INTL position peaked at $843K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q2 2014.

Based on Long Wharf Investors's 13F filing for Q2 2014, filed 4 Aug 2014.